Skip to main content
Innovation in Aging logoLink to Innovation in Aging
. 2018 Nov 11;2(Suppl 1):54. doi: 10.1093/geroni/igy023.201

DOPAMINERGIC GENOTYPE AND RESILIENCE TO SMALL VESSEL DISEASE ASSOCIATIONS WITH SLOWER GAIT SPEED

A L Rosso 1, N I Bohnen 2, L J Launer 3, H J Aizenstein 4, K Yaffe 5, C Rosano 4
PMCID: PMC6227135

Abstract

We assessed associations of slow gait with measures of dopaminergic (catechol-O-methyltransferase (COMT) genotype, indicator of synaptic dopamine levels) and vascular (white matter hyperintensities (WMH), dichotomized at the median) factors in a cohort of older adults (n=215; age= 82.6 (SD=2.6); 58.0% female; 38.8% black; 35 Met/Met COMT Val158Met (higher dopamine) genotype). Mean gait speed was 0.92 m/s. There was a significant interaction (p=0.048) between WMH and COMT. Stratified analyses reveled a strong association between WMH and gait speed among COMT Val carriers (beta=-9.9, CI: -16.5, -3.3; lower dopamine), but not for Met/Met (beta=5.3, CI: -14.4, 24.9; higher dopamine) independent of covariates. Differences persisted over four years of follow-up. Higher synaptic dopamine, as indicated by COMT genotype, may have a protective effect on gait speed in the presence of WMH. The dopaminergic system may be an intervention target for increasing brain resilience and enhancing functional outcomes in older adults.


Articles from Innovation in Aging are provided here courtesy of Oxford University Press

RESOURCES